Status:
COMPLETED
Transcutaneous Spinal Cord Neuromodulation to Normalize Autonomic Phenotypes
Lead Sponsor:
Spaulding Rehabilitation Hospital
Collaborating Sponsors:
Medical University of South Carolina
Conditions:
Spinal Cord Injuries
Autonomic Imbalance
Eligibility:
All Genders
18-30 years
Phase:
NA
Brief Summary
This study looks to characterize autonomic nervous system dysfunction after spinal cord injury and identify the potential role that transcutaneous spinal cord stimulation may play at altering neuroreg...
Eligibility Criteria
Inclusion
- All participants
- \- age 18-30 years old.
- Participants with spinal cord injury
- Adult onset, traumatic spinal cord injury.
- Time since injury 1 year, in an effort to limit baroreflex desensitization.
- American Spinal Injury Association Impairment Scale, A, to limit potential confounders.
- Neurological level of injury, T1-T6, as defined by the International Standards for Neurological Classification of Spinal Cord Injury.
Exclusion
- History of cardiovascular disease, hypertension, neurologic disorders (with exception of spinal cord injury), or diabetes.
- Women who are pregnant or lactating.
- Currently taking blood thinners.
- Taking anti-hypertensive or other medication that could influence any of the dependent autonomic variables.
Key Trial Info
Start Date :
February 17 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 14 2022
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT04858178
Start Date
February 17 2022
End Date
November 14 2022
Last Update
April 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Spaulding Rehabilitation Hospital
Boston, Massachusetts, United States, 02129